555 related articles for article (PubMed ID: 28799485)
1. Monoclonal Antibodies: A Review.
Singh S; Kumar NK; Dwiwedi P; Charan J; Kaur R; Sidhu P; Chugh VK
Curr Clin Pharmacol; 2018; 13(2):85-99. PubMed ID: 28799485
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-based molecular imaging strategies and theranostic opportunities.
Dammes N; Peer D
Theranostics; 2020; 10(2):938-955. PubMed ID: 31903161
[TBL] [Abstract][Full Text] [Related]
3. Emerging trends and therapeutic applications of monoclonal antibodies.
Mekala JR; Nalluri HP; Reddy PN; S B S; N S SK; G V S D SK; Dhiman R; Chamarthy S; Komaragiri RR; Manyam RR; Dirisala VR
Gene; 2024 Oct; 925():148607. PubMed ID: 38797505
[TBL] [Abstract][Full Text] [Related]
4. New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies.
Robak T; Robak E
BioDrugs; 2011 Feb; 25(1):13-25. PubMed ID: 21090841
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies in human organ transplantation and auto-immune diseases.
Wijdenes J; Roy C; Morel-Fourrier B; Racadot E
Therapie; 1992; 47(4):283-7. PubMed ID: 1494788
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic use of monoclonal antibodies].
Baron D
Naturwissenschaften; 1997 May; 84(5):189-98. PubMed ID: 9273448
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic human monoclonal antibodies against cancer.
Jarboe J; Gupta A; Saif MW
Methods Mol Biol; 2014; 1060():61-77. PubMed ID: 24037836
[TBL] [Abstract][Full Text] [Related]
8. Development trends for human monoclonal antibody therapeutics.
Nelson AL; Dhimolea E; Reichert JM
Nat Rev Drug Discov; 2010 Oct; 9(10):767-74. PubMed ID: 20811384
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal Antibody Biosimilars in Oncology: Critical Appraisal of Available Data on Switching.
Declerck P; Bakalos G; Zintzaras E; Barton B; Schreitmüller T
Clin Ther; 2018 May; 40(5):798-809.e2. PubMed ID: 29699853
[TBL] [Abstract][Full Text] [Related]
10. New monoclonal antibodies in renal transplantation.
Vincenti F
Minerva Urol Nefrol; 2003 Mar; 55(1):57-66. PubMed ID: 12773967
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
Rao AV; Schmader K
Am J Geriatr Pharmacother; 2007 Sep; 5(3):247-62. PubMed ID: 17996665
[TBL] [Abstract][Full Text] [Related]
12. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
[TBL] [Abstract][Full Text] [Related]
13. Pricing of monoclonal antibody therapies: higher if used for cancer?
Hernandez I; Bott SW; Patel AS; Wolf CG; Hospodar AR; Sampathkumar S; Shrank WH
Am J Manag Care; 2018 Feb; 24(2):109-112. PubMed ID: 29461857
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Monoclonal Antibodies in Clinical Practice against Cancer.
Kaur N; Goyal A; Sindhu RK
Anticancer Agents Med Chem; 2020; 20(16):1895-1907. PubMed ID: 32619180
[TBL] [Abstract][Full Text] [Related]
16. Quality Control of Therapeutic Monoclonal Antibodies at the Hospital After Their Compounding and Before Their Administration to Patients.
Jaccoulet E; Smadja C; Taverna M
Methods Mol Biol; 2016; 1466():179-84. PubMed ID: 27473490
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies in pediatrics: use in prevention and treatment.
Martin-Mateos MA
Allergol Immunopathol (Madr); 2007; 35(4):145-50. PubMed ID: 17663923
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies in cancer therapy.
Gatto B
Curr Med Chem Anticancer Agents; 2004 Sep; 4(5):411-4. PubMed ID: 15379694
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive monoclonal antibodies: current and next generation.
Focosi D; Maggi F; Pistello M; Boggi U; Scatena F
Clin Microbiol Infect; 2011 Dec; 17(12):1759-68. PubMed ID: 21995285
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of monoclonal antibody-drug interactions.
Zhou H; Mascelli MA
Annu Rev Pharmacol Toxicol; 2011; 51():359-72. PubMed ID: 20936946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
